CREIDU: Centre for Research Excellence into Injecting Drug Use

Featuring academic partners from the Burnet Institute, the National Drug and Alcohol Research Centre, the Kirby Institute, Turning Point Alcohol and Drug Centre, the National Drug Research Institute and the School of Population Health at the University of Queensland, the Centre unites Australia’s leading researchers with community organisations, Anex, Harm Reduction Victoria, Hepatitis C Victoria and government, including the ACT Corrections Health Program.

Facilitating Collaborations:

Between researchers and workers in the fields of justice health, mental health, blood-borne virus infection, alcohol and drug use, addiction and policy research.

Education and Training:

For students, early-career researchers and community sector workers in disciplines relating to the health of people who inject drugs.

Communicating Research:

Research findings and translation of research into policy and practice.

Supporting New Research:

Provision of seed funding to support new and novel research projects.

Burnet’s Professor Margaret Hellard, a Lead Investigator with CREIDU, says the strengthened links forged between researchers also benefits the communities they serve.

“The Centre’s focus is to increase our knowledge about IDU and its health and social effects, so ultimately we can identify ways to prevent or reduce the severity of health and social outcomes through policy and practice.“ she said.

“What also makes this NHMRC-funded project unique is that we also bring together experts from IDU-related areas such as blood-borne virus, epidemiology and treatment (particularly hepatitis C), overdose prevention, justice health and psychiatric health.

“Australia’s research capacity in illicit drug epidemiology will also be enhanced by CREIDU supporting postdoctoral-fellows and PhD students.”

CREIDU website -

Find out more about the investigators, the research projects underway and the policy briefs at


Resources & Policy Briefs

Among the Policy Briefs available on the CREIDU website are:

  • Confronting reality: opportunities to address injecting drug use in correctional settings by Doctor Mark Stoové (2012)
  • High-risk injecting drug use after release from prison by Associate Professor Stuart Kinner (2012)
  • Proposed Victorian Alcohol and Drug Treatment Principles - Submission - by Trevor King (2012)
  • Increasing hepatitis B vaccination in people who inject drugs by Professor Lisa Maher (2012)
  • Improving responses to opioid overdose through naloxone by Professor Paul Dietze and Professor Simon Lenton (2012)
  • People who inject drugs can be successfully treated for hepatitis C (HCV), and treatment has the potential to reduce the community prevalence of HCV by Professor Margaret Hellard (2012)
  • Safe injecting facilities: reducing harm and improving public safety and amenity by Professor Robert Power (2011)
  • Future directions in hepatitis C treatment: closing in on a cure for the vast majority by Professor Greg Dore (2011)


  • Burnet Institute
  • Drug Policy Modelling Program (DPMP)
  • The Kirby Institute
  • Turning Point Alcohol & Drug Centre
  • National Drug Research Institute (NDRI)
  • University of Queensland School of Population Health
  • Australian National University
  • Anex Australia
  • Harm Reduction Victoria
  • Hepatitis Victoria
  • University of Melbourne


CREIDU is funded by the National Health and Medical Research Council (NHMRC). Grant Number 1001144.

Contact Details

For any general enquiries relating to this project, please contact:

Professor Paul Dietze

Program Director, Behaviours and Health Risks




[email protected]